Home monitoring to detect progression of interstitial lung disease: A prospective cohort study.

This article explores the potential benefits of home monitoring for patients with interstitial lung disease (ILD). It suggests that traditional measures of disease severity may not fully capture the complexities of ILD, and home monitoring, particularly home-spirometry, has shown promise in predicting outcomes and correlating with hospital-spirometry. However, there is limited evidence supporting the continuous monitoring of physiological parameters and symptoms in detecting disease progression or response to treatment. The study discussed in the article evaluated a real-time multimodal program using commercially available technology to monitor ILD patients over 26 weeks. The study found differences in baseline characteristics between patients who progressed and those who remained stable, and further research is needed to explore the potential of continuous home monitoring in managing ILD. [Extracted from the article]